drugset / Trial / NCT00832052
A Study to Evaluate Safety, Tolerability, Plasma Drug Levels, and Cognitive Response Following Multiple Doses of a Drug in Healthy Elderly Participants.
RandomizedParallel-groupDouble-blind
Summary
Evaluate the safety and tolerability of PF-04447943 after administration of multiple doses in healthy elderly participants. Evaluate plasma drug levels and effects on cognition.
Timeline
- Start
- 2009-01
- Primary completion
- 2009-05
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EDELINONTRINE | Small molecule | 5 mg | Oral |
| Subject | EDELINONTRINE | Small molecule | 15 mg | Oral |
| Subject | EDELINONTRINE | Small molecule | 35 mg | Oral |
Indications
No indication recorded.